21 reports of this reaction
5.4% of all DEXTROMETHORPHAN HBR reports
#2 most reported adverse reaction
CARDIAC ARREST is the #2 most commonly reported adverse reaction for DEXTROMETHORPHAN HBR, manufactured by Best Choice (Valu Merchandisers Company). There are 21 FDA adverse event reports linking DEXTROMETHORPHAN HBR to CARDIAC ARREST. This represents approximately 5.4% of all 389 adverse event reports for this drug.
Patients taking DEXTROMETHORPHAN HBR who experience cardiac arrest should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CARDIAC ARREST is moderately reported among DEXTROMETHORPHAN HBR users, representing a notable but not dominant share of adverse events.
In addition to cardiac arrest, the following adverse reactions have been reported for DEXTROMETHORPHAN HBR:
The following drugs have also been linked to cardiac arrest in FDA adverse event reports:
CARDIAC ARREST has been reported as an adverse event in 21 FDA reports for DEXTROMETHORPHAN HBR. This does not prove causation, but indicates an association observed in post-market surveillance data.
CARDIAC ARREST accounts for approximately 5.4% of all adverse event reports for DEXTROMETHORPHAN HBR, making it one of the most commonly reported side effect.
If you experience cardiac arrest while taking DEXTROMETHORPHAN HBR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.